Guorong Xu
- Surgery top 2%
- Cholesterol and Lipid Metabolism 37
- Pediatric Hepatobiliary Diseases and Treatments 7
- Oncology top 5%
- Drug Transport and Resistance Mechanisms 34
- Biochemistry top 5%
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 4
-
- Peroxisome Proliferator-Activated Receptors 11
- Steroid Chemistry and Biochemistry 4
-
- Liver Disease Diagnosis and Treatment 6
-
- Membrane Separation Technologies 4
- Co-authors
- Gerald SalenAkira HondaAshok K. BattaSarah SheferG. Stephen TintQuan ShangG S TintTeruo Miyazaki
- Cited by
- SurgeryOncologyBiochemistry
- Journals
- Journal of Lipid Research (16 papers)Metabolism (8 papers)American Journal of Physiology-Gastrointestinal and Liver Physiology (6 papers)
- Partner nations
- United StatesJapanChina
In The Last Decade
Guorong Xu
67 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 124
- Surgery 1.2k
- Oncology 678
- Biochemistry 147
- Pharmacology 160
- Endocrinology, Diabetes and Metabolism 265
Countries citing papers authored by Guorong Xu
This map shows the geographic impact of Guorong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guorong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guorong Xu more than expected).
Fields of papers citing papers by Guorong Xu
This network shows the impact of papers produced by Guorong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guorong Xu. The network helps show where Guorong Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guorong Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 6 | |
| 2 | 2024 | 10 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 5 | |
| 6 | 2023 | 22 | |
| 7 | 2023 | 7 | |
| 8 | 2023 | 14 | |
| 9 | 2023 | 15 | |
| 10 | Electroactivities of Pd/Fe3O4-C catalysts for electro-oxidation of methanol, ethanol and propanol | 2017 | 2 |
| 11 | 2007 | 7 | |
| 12 | 2006 | 8 | |
| 13 | 2004 | 33 | |
| 14 | 2004 | 26 | |
| 15 | 2004 | 16 | |
| 16 | 2004 | 72 | |
| 17 | 2002 | 10 | |
| 18 | 2001 | 63 | |
| 19 | 1998 | 13 | |
| 20 | 1992 | 25 |
About Guorong Xu
Guorong Xu is a scholar working on Oncology, Surgery, Pharmacology, Water Science and Technology and Molecular Biology, having authored 69 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (37 papers), Drug Transport and Resistance Mechanisms (34 papers), Peroxisome Proliferator-Activated Receptors (11 papers), Pediatric Hepatobiliary Diseases and Treatments (7 papers), Liver Disease Diagnosis and Treatment (6 papers), Pharmacogenetics and Drug Metabolism (4 papers), Membrane Separation Technologies (4 papers) and Steroid Chemistry and Biochemistry (4 papers). The work is most often cited by research in Surgery (1.2k citations), Oncology (678 citations), Biochemistry (147 citations), Pharmacology (160 citations) and Endocrinology, Diabetes and Metabolism (265 citations). Guorong Xu has collaborated with scholars based in United States, Japan and China. Frequent co-authors include Gerald Salen, Akira Honda, Ashok K. Batta, Sarah Shefer, G. Stephen Tint, Quan Shang, G S Tint, Teruo Miyazaki, Yasushi Matsuzaki and Tadashi Ikegami. Their work appears in journals such as Journal of Lipid Research, Metabolism, American Journal of Physiology-Gastrointestinal and Liver Physiology, Gastroenterology and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.